North America Artificial Blood Market : By Product Type (Hemoglobin-Based Oxygen Carriers, Perflurocarbon-Based Products, Recombinant Factors, Synthetic Platelets, Plasma Expanders, Others), By Application (Traumatic Injuries, Blood Disorders, Anemia, Surgeries, Others), By Distribution Channel (Hospitals, Clinics, Blood Banks), and Country  

Purchase Option

$ 3100
$ 4600
$ 6900

North America Artificial Blood Market size was expected to grow at a CAGR of x% during the forecast period 2023 to 2029. Artificial blood or synthetic blood and blood products are the alternatives to the blood transfusion to replace the blood. It fulfills and replicates the normal functions of the body. Artificial blood is infused in the traumatic injuries and other disease conditions for the transportation of carbon di oxide and oxygen across the body. Moreover, scientists are focusing on the development of artificial blood due to inadequate number of blood donors leads to shortage of blood. However, there are adverse effects associated with the artificial blood such as hemoglobin based blood substitute might increase the occurrence of heart attacks. Lower shelf-life and instability of artificial blood, Adverse effects associated with artificial blood substitutes and Stringent regulatory guidelines for product approval are restraints of North America Artificial Blood Market. This report presents market dynamics elaborately to identify the current market trends & drivers, future opportunities and possible challenges to the key stakeholders operating in the market. In addition, market report includes the competition analysis with vividly illustrated the competition dashboard to assess the market competition. 

North America Artificial Blood Market Dynamics

Increase in the prevalence of anemia and other blood disorders, Rise in R&D for the innovation of newer products and Increase in healthcare expenditure and well developed healthcare infrastructure are driving North America Artificial Blood Market.

Key Features of the Reports

  • The report provides granular level information about the market size, regional market share, historic market (2018 to 2022) and forecast (2023 to 2029)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides plethora of information about market entry strategies, regulatory framework and reimbursement scenario
  • The report analyses the impact of socio-political environment through PESTLE Analysis and competition through Porter’s Five Force Analysis in addition to recent technology advancements and innovations in the market

North America Artificial Blood Market Segmentation

By Product Type
  • Hemoglobin-Based Oxygen Carriers
  • Perflurocarbon-Based Products
  • Recombinant Factors
  • Synthetic Platelets
  • Plasma Expanders
  • Others
By Application
  • Traumatic Injuries
  • Blood Disorders
  • Anemia
  • Surgeries
  • Others
By Distribution Channel
  • Hospitals
  • Clinics
  • Blood Banks

Frequently Asked Questions

The key segments covered in the North America Artificial Blood Market are: by Product Type, Application, Distribution Channel

The report covers the five regions and 15+ countries market data: North America (United States, Canada), Europe (Germany, France, Italy, Spain, and United Kingdom (UK), Asia Pacific (China, India, Japan, Australia & New Zealand), Latin America (Brazil, Mexico, Argentina) and Middle East and Africa (Saudi Arabia, United Arab Emirates, South Africa).

In our report, we provide 12-15 market players’ information into the report. However, based on the client’s request we will provide additional country and regional market players information as well.

1.Executive Summary
2.North America Artificial Blood Market Introduction 
2.1.North America Artificial Blood Market  - Taxonomy
2.2.North America Artificial Blood Market  - Definitions
2.2.1.Product Type
2.2.2.Application
2.2.3.Distribution Channel
2.2.4.Region
3.North America Artificial Blood Market Dynamics
3.1. Drivers
3.2. Restraints
3.3. Opportunities/Unmet Needs of the Market
3.4. Trends
3.5. Product Landscape
3.6. New Product Launches
3.7. Impact of COVID 19 on Market
4.North America Artificial Blood Market Analysis, 2018-2022 and Forecast 2023-2029
4.1.  Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
4.2.  Year-Over-Year (Y-o-Y) Growth Analysis (%) 
4.3.  Market Opportunity Analysis 
5.North America Artificial Blood Market  By Product Type, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
5.1. Hemoglobin-Based Oxygen Carriers
5.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.1.3. Market Opportunity Analysis 
5.2. Perflurocarbon-Based Products
5.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.2.3. Market Opportunity Analysis 
5.3. Recombinant Factors
5.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.3.3. Market Opportunity Analysis 
5.4. Synthetic Platelets
5.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.4.3. Market Opportunity Analysis 
5.5. Plasma Expanders
5.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.5.3. Market Opportunity Analysis 
5.6. Others
5.6.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
5.6.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
5.6.3. Market Opportunity Analysis 
6.North America Artificial Blood Market  By Application, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
6.1. Traumatic Injuries
6.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.1.3. Market Opportunity Analysis 
6.2. Blood Disorders
6.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.2.3. Market Opportunity Analysis 
6.3. Anemia
6.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.3.3. Market Opportunity Analysis 
6.4. Surgeries
6.4.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.4.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.4.3. Market Opportunity Analysis 
6.5. Others
6.5.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
6.5.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
6.5.3. Market Opportunity Analysis 
7.North America Artificial Blood Market  By Distribution Channel, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
7.1. Hospitals, Clinics
7.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.1.3. Market Opportunity Analysis 
7.2. Blood Banks
7.2.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.2.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.2.3. Market Opportunity Analysis 
7.3. Online Pharmacies
7.3.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
7.3.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
7.3.3. Market Opportunity Analysis 
8.North America Artificial Blood Market  By Region, 2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
8.1. North America
8.1.1. Market Analysis, 2018-2022 and Forecast, 2023-2029, (Sales Value USD Million)
8.1.2. Year-Over-Year (Y-o-Y) Growth Analysis (%) and Market Share Analysis (%) 
8.1.3. Market Opportunity Analysis 
9.North America North America Artificial Blood Market ,2018-2022 and Forecast 2023-2029 (Sales Value USD Million)
9.1. Product Type Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.1.1.Hemoglobin-Based Oxygen Carriers
9.1.2.Perflurocarbon-Based Products
9.1.3.Recombinant Factors
9.1.4.Synthetic Platelets
9.1.5.Plasma Expanders
9.1.6.Others
9.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.2.1.Traumatic Injuries
9.2.2.Blood Disorders
9.2.3.Anemia
9.2.4.Surgeries
9.2.5.Others
9.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.3.1.Hospitals, Clinics
9.3.2.Blood Banks
9.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
9.4.1.United States of America (USA)
9.4.2.Canada
10.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.2.1.Traumatic Injuries
10.2.2.Blood Disorders
10.2.3.Anemia
10.2.4.Surgeries
10.2.5.Others
10.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
10.3.1.Hospitals, Clinics
10.3.2.Blood Banks
10.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.2.1.Traumatic Injuries
11.2.2.Blood Disorders
11.2.3.Anemia
11.2.4.Surgeries
11.2.5.Others
11.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
11.3.1.Hospitals, Clinics
11.3.2.Blood Banks
11.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.2.1.Traumatic Injuries
12.2.2.Blood Disorders
12.2.3.Anemia
12.2.4.Surgeries
12.2.5.Others
12.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
12.3.1.Hospitals, Clinics
12.3.2.Blood Banks
12.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.  Application Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.2.1.Traumatic Injuries
13.2.2.Blood Disorders
13.2.3.Anemia
13.2.4.Surgeries
13.2.5.Others
13.3.  Distribution Channel Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
13.3.1.Hospitals, Clinics
13.3.2.Blood Banks
13.4.  Country Analysis 2018-2022 and Forecast 2023-2029 by Sales Value USD Million, Y-o-Y Growth (%), and Market Share (%) 
14. Competition Landscape
14.1.  Market Player Profiles (Introduction, Brand/Product Sales, Financial Analysis, Product Offerings, Key Developments, Collaborations, M & A, Strategies, and SWOT Analysis) 
14.2.1.FluorO2 Therapeutics
14.2.2.Alpha Therapeutic Corp 
15. Research Methodology 
16. Appendix and Abbreviations 

 

  • FluorO2 Therapeutics
  • Alpha Therapeutic Corp 

Adjacent Markets